Human prostatic acid phosphatases. II. A double-antibody radioimmunoassay

B. K. Choe, E. J. Pontes, M. K. Morrison, N. R. Rose

Research output: Contribution to journalArticle

Abstract

A double-antibody radioimmunoassay method for prostate-specific acid phosphatase (PAP) is presented. Experimental details are outlined to assess the reproducibility and reliability of the method under various assay conditions. The upper limit of the serum PAP levels in the present assay was set at 2.4 ng/100 μl by 162 determinations of normal serum samples. The serum PAP levels of patients with nonprostatic malignant tumors fell in the normal range, whereas the levels higher than 4.0 ng/100 μl were found in patients with prostatic carcinoma.

Original languageEnglish (US)
Pages (from-to)227-233
Number of pages7
JournalArchives of Andrology
Volume1
Issue number3
StatePublished - 1978
Externally publishedYes

Fingerprint

Acid Phosphatase
Radioimmunoassay
Prostate
Antibodies
Serum
Reference Values
Carcinoma
prostatic acid phosphatase
Neoplasms

ASJC Scopus subject areas

  • Endocrinology

Cite this

Choe, B. K., Pontes, E. J., Morrison, M. K., & Rose, N. R. (1978). Human prostatic acid phosphatases. II. A double-antibody radioimmunoassay. Archives of Andrology, 1(3), 227-233.

Human prostatic acid phosphatases. II. A double-antibody radioimmunoassay. / Choe, B. K.; Pontes, E. J.; Morrison, M. K.; Rose, N. R.

In: Archives of Andrology, Vol. 1, No. 3, 1978, p. 227-233.

Research output: Contribution to journalArticle

Choe, BK, Pontes, EJ, Morrison, MK & Rose, NR 1978, 'Human prostatic acid phosphatases. II. A double-antibody radioimmunoassay', Archives of Andrology, vol. 1, no. 3, pp. 227-233.
Choe BK, Pontes EJ, Morrison MK, Rose NR. Human prostatic acid phosphatases. II. A double-antibody radioimmunoassay. Archives of Andrology. 1978;1(3):227-233.
Choe, B. K. ; Pontes, E. J. ; Morrison, M. K. ; Rose, N. R. / Human prostatic acid phosphatases. II. A double-antibody radioimmunoassay. In: Archives of Andrology. 1978 ; Vol. 1, No. 3. pp. 227-233.
@article{7ca0284536c64aaeb931a965967ef159,
title = "Human prostatic acid phosphatases. II. A double-antibody radioimmunoassay",
abstract = "A double-antibody radioimmunoassay method for prostate-specific acid phosphatase (PAP) is presented. Experimental details are outlined to assess the reproducibility and reliability of the method under various assay conditions. The upper limit of the serum PAP levels in the present assay was set at 2.4 ng/100 μl by 162 determinations of normal serum samples. The serum PAP levels of patients with nonprostatic malignant tumors fell in the normal range, whereas the levels higher than 4.0 ng/100 μl were found in patients with prostatic carcinoma.",
author = "Choe, {B. K.} and Pontes, {E. J.} and Morrison, {M. K.} and Rose, {N. R.}",
year = "1978",
language = "English (US)",
volume = "1",
pages = "227--233",
journal = "Systems Biology in Reproductive Medicine",
issn = "1939-6368",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Human prostatic acid phosphatases. II. A double-antibody radioimmunoassay

AU - Choe, B. K.

AU - Pontes, E. J.

AU - Morrison, M. K.

AU - Rose, N. R.

PY - 1978

Y1 - 1978

N2 - A double-antibody radioimmunoassay method for prostate-specific acid phosphatase (PAP) is presented. Experimental details are outlined to assess the reproducibility and reliability of the method under various assay conditions. The upper limit of the serum PAP levels in the present assay was set at 2.4 ng/100 μl by 162 determinations of normal serum samples. The serum PAP levels of patients with nonprostatic malignant tumors fell in the normal range, whereas the levels higher than 4.0 ng/100 μl were found in patients with prostatic carcinoma.

AB - A double-antibody radioimmunoassay method for prostate-specific acid phosphatase (PAP) is presented. Experimental details are outlined to assess the reproducibility and reliability of the method under various assay conditions. The upper limit of the serum PAP levels in the present assay was set at 2.4 ng/100 μl by 162 determinations of normal serum samples. The serum PAP levels of patients with nonprostatic malignant tumors fell in the normal range, whereas the levels higher than 4.0 ng/100 μl were found in patients with prostatic carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0018258653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018258653&partnerID=8YFLogxK

M3 - Article

C2 - 83815

VL - 1

SP - 227

EP - 233

JO - Systems Biology in Reproductive Medicine

JF - Systems Biology in Reproductive Medicine

SN - 1939-6368

IS - 3

ER -